Theoretical study of chemical reactivity descriptors of some repurposed drugs for COVID-19

被引:11
|
作者
Morad, Razieh [1 ]
Akbari, Mahmood [2 ]
Maaza, Malik [1 ,2 ]
机构
[1] Univ South Africa UNISA, Coll Grad Studies, UNESCO UNISA iTLABS Africa Chair Nanosci & Nanotec, Pretoria, South Africa
[2] Natl Res Fdn, Mat Res Div, iThemba LABS, Nanosci African Network NANOAFNET, ZA-7129 Somerset West, South Africa
关键词
D O I
10.1557/s43580-023-00590-6
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
This study focuses on computational studies of chemical reactivity descriptors of some proposed drugs for COVID-19. Density functional theory calculations were used to optimize the structure and investigate the frontier orbitals and the chemical reactivity descriptors of these drugs. The frontier orbitals, which include both the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO), play an essential role in molecular interactions and chemical reactivity of molecule. Polarizability, which determines the response of the susceptibility of a molecule to an approaching charge, is higher in the more complex drugs such as Hydroxychloroquine, Remdesivir, and Ivermectin compare to the smaller drugs. The HOMO and LUMO orbital energies were calculated to obtain the energy gap of the studied drugs, which is in the following order: Favipiravir < Hydroxychloroquine, Remdesivir < Ivermectin < Artesunate < Artemether < Artemisinin. Generally, molecules with a larger energy gap have lower chemical reactivity and higher kinetic stability.
引用
收藏
页码:656 / 660
页数:5
相关论文
共 50 条
  • [31] Molecular Descriptors of Some Chemicals that Prevent COVID-19
    Mondal, Sourav
    De, Nilanjan
    Pal, Anita
    Gao, Wei
    CURRENT ORGANIC SYNTHESIS, 2021, 18 (08) : 729 - 741
  • [32] Potential repurposed SARS-CoV-2 (COVID-19) infection drugs
    Abuo-Rahma, Gamal El-Din A.
    Mohamed, Mamdouh F. A.
    Ibrahim, Tarek S.
    Shoman, Mai E.
    Samir, Ebtihal
    Abd El-Baky, Rehab M.
    RSC ADVANCES, 2020, 10 (45) : 26895 - 26916
  • [33] Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
    Badary, Osama A.
    PHARMACOGENOMICS JOURNAL, 2021, 21 (03): : 275 - 284
  • [34] A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19
    Kushwaha, Narva Deshwar
    Mohan, Jivanka
    Kushwaha, Babita
    Ghazi, Terisha
    Nwabuife, Joshua C.
    Koorbanally, Neil
    Chuturgoon, Anil A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 260
  • [35] A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
    Banerjee, Surojit
    Banerjee, Debadri
    Singh, Anupama
    Kumar, Sumit
    Pooja, Deep
    Ram, Veerma
    Kulhari, Hitesh
    Saharan, Vikas Anand
    VACCINES, 2023, 11 (02)
  • [36] Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
    Alegria-Arcos, Melissa
    Barbosa, Tabata
    Sepulveda, Felipe
    Combariza, German
    Gonzalez, Janneth
    Gil, Carmen
    Martinez, Ana
    Ramirez, David
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
    Baburaj, Gayathri
    Thomas, Levin
    Rao, Mahadev
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (03) : 261 - 269
  • [38] A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
    Costa, Barbara
    Vale, Nuno
    PHARMACEUTICS, 2021, 13 (06)
  • [39] COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
    Suet-May, Chow
    Sin-Yee, Kuok
    Jia-Qing, Lee
    Pey-Wen, Goh
    Singh, Harleen Kaur A. P. Ranjit
    Zhi-Zheng, Timothy Tan
    Foo, Jhi-Biau
    Hamzah, Sharina
    Sellappans, Renukha
    Hui-Yin, Yow
    SUDAN JOURNAL OF MEDICAL SCIENCES, 2022, 17 (04): : 498 - 538
  • [40] Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
    Osama A. Badary
    The Pharmacogenomics Journal, 2021, 21 : 275 - 284